HEATHER HUNTER: Open Payments
NPI 1316694854 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$202 in 11 payments from 9 companies in 2025. Trend: 2023 $955 · 2024 $891 · 2025 $202
Food & beverage: $202
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $38 |
| PFIZER INC. | 2 | $35 |
| Dexcom, Inc. | 1 | $27 |
| Novo Nordisk Inc | 1 | $22 |
| Viatris Specialty LLC | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $13 |
Products named: Dexcom G6 Transmitter, Ozempic, QULIPTA, ELIQUIS, YUPELRI, AIRSUPRA, UBRELVY, LEQVIO.
Industry payments across FL — which companies pay providers there.
